Establishing Comprehensive Donor Characterization Panels to Predict Manufacturing Performance & Reduce Process Failures

9:00 am - Monday 7th December 2026

  • Identifying critical quality attributes in starting material that correlate with expansion rates, cell viability and final product yield to minimize costly manufacturing failures
  • Implementing upfront screening assays to characterize donor health status, cellular phenotype and functional markers before committing to full-scale production
  • Leveraging characterization data to reduce time spent evaluating unsuitable donors and accelerate selection of high-performing material for consistent output

Speakers:

Chief Scientific Officer
Indapta Therapeutics